ODAM PAPILLOMA VIRUSIGA QARSHI VAKSINALAR ISTIQBOLI

Authors
  • Abdurahmonova K.R.

    TDTU Mikrobiologiya, virusologiya, immunologiya kafedrasi assistenti

    Author

  • Dushayev Z.A

    TDTU 1- Davolash fakulteti talabasi

    Author

  • Yakupbayeva N.G

    TDTU 1-Davolash fakulteti talabasi

    Author

  • Xasanova D.X

    TDTU 1-Davolash fakulteti talabasi

    Author

Keywords:
Array
Abstract

Ushbu maqola odam papilloma virusi (OPV) bilan bog‘liq infeksiyalarni o‘rganishning zamonaviy laboratoriya yondashuvlarini va ularning serologik va profilaktik ahamiyatini ko‘rib chiqadi. Maqolada serologik va molekulyar-genetik metodlar, xususan polimeraza zanjir reaksiyasining turli modifikatsiyalari (Real-Time PCR, Multiplex PCR, Long-range PCR) orqali virusni aniqlash va uning onkogenezdagi rolini baholash imkoniyatlari tahlil qilinadi. Shuningdek, maqolada immunoanalitik metodlar va serologik testlarning laboratoriya amaliyotida qo‘llanilishi, ularning samaradorligi va texnik qulayligi ta’kidlanadi. Ushbu yondashuvlar OPV infektsiyasini erta aniqlash, kasallik xavfini baholash va profilaktik tadbirlarni optimallashtirishda muhim vosita sifatida xizmat qiladi. Maqola natijalari zamonaviy diagnostika va profilaktika strategiyalarini rivojlantirish, shuningdek, OPV bilan bog‘liq onkologik kasalliklarni kamaytirishga yo‘naltirilgan ilmiy va amaliy tadqiqotlarni qo‘llab-quvvatlash imkonini beradi.

References

1.Bayramova G.R., et al., 2024. Quantitative and qualitative determination of human papillomavirus DNA in women with cervical lesions. Obstetrics and Gynecology, p. 102109

2.Belokrinitskaya A., et al., 2014. Results of human papillomavirus testing on selfcollected vs cliniciancollected samples. Gynecology Journal, p. 74

3.Bruni L., et al., 2023. Human papillomavirus and related diseases report. ICO/IARC Information Centre on HPV and Cancer, p. 12-15

4.Centers for Disease Control and Prevention, 2025. HPV Clinical Features and Management. CDC, Atlanta, p. 4-6

5.Centers for Disease Control and Prevention, 2025. Updates on HPV vaccine and cancer prevention. CDC, Atlanta, p. 4

6.Doorbar J., et al., 2015. The biology and life-cycle of human papillomaviruses. Vaccine, 33 Suppl 1: p. A7 A13

7.Ferlay J., et al., 2022. Global Cancer Observatory: Cancer Today. IARC, Lyon, p. 14

8.Gillison M.L., et al., 2000. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. Journal of the National Cancer Institute, 92(9): p. 709720

9.Lyalina I.V., et al., 2021. Diagnosis of premalignant and malignant cervix diseases in HPVpositive females, Gynecology Journal, p. 45

10.Mamaraсулова D.Z., et al., 2022. Testing of HPV in primary cervical pathology screening. Andijan State Medical Institute Journal, p. 158161

11.Mullis K., et al., 1986. Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction. Cold Spring Harbor Symposia, p. 263273

12.Osmani V., et al., 2025. Worldwide burden of cervical human papillomavirus in women over 50 with abnormal cytology. BMJ Global Health, p. 6

13.Schiffman M., et al., 2016. HPV testing in cervical cancer prevention. Journal of Clinical Microbiology, 54(10): p. 2452

14.Smith J.S., et al., 2007. Transmission of HPV from mother to child. Lancet Infectious Diseases, 7(5): p. 297303

15.Stanley M.A., et al., 2022. Development of human papillomavirus and its detection methods; Journal of Virological Methods, p. 89-95

16.Walboomers J.M., et al., 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189(1): p. 1219

17.World Health Organization, 2023. “One in three men worldwide are infected with genital HPV”. WHO, Geneva, p.1-7

18.World Health Organization, 2025. HPV and cervical cancer fact sheet. WHO, Geneva, p. 2-3

19.World Health Organization, 2025. HPV test implementation guidance. WHO, Geneva, p. 14

20.World Health Organization, 2025. Human Papillomavirus (HPV) and Cervical Cancer fact sheet. WHO, Geneva, p. 1

Cover Image
Downloads
Published
2026-05-05
Section
Articles